Deltex Medical Group PLC
28 March 2006
Deltex Medical Group Plc (the 'Company)
Grant of Options
Deltex Medical Group plc, the AIM listed haemodynamic monitoring company,
announces that the Board has today approved the issue of contractual share
options to Andy Hill, Chief Executive and Ewan Phillips, Finance Director under
the Company's 2001 Executive Share Option Scheme. The details are as follows:
Name No. of options Exercise Exercise period from Exercise period to
Price £
Andy Hill 400,000 0.2075 28 March 2009 27 March 2016
Ewan Phillips 400,000 0.2075 28 March 2009 27 March 2016
In addition to the options outlined above, Mr Hill has an interest in the
following:
Name No. of Exercise Exercise period from Exercise period to
options
Price £
Executive Share Option
Scheme
200,000 0.25 27 November 2005 26 November 2012
200,000 0.15 28 October 2006 27 October 2013
400,000 0.24 12 October 2007 11 October 2014
EMI Scheme* 333,333 0.01 24 March 2004 27 October 2013
156,739 0.01 15 March 2005 11 October 2014
In addition to the options outlined above, Mr Phillips has an interest in the
following:
Name No. of Exercise Exercise period from Exercise period to
options
Price £
Executive Share Option
Scheme
100,000 0.25 7 November 2004 6 November 2011
60,000 0.25 27 November 2005 26 November 2012
120,000 0.15 28 October 2006 27 October 2013
400,000 0.24 12 October 2007 11 October 2014
EMI Scheme* 583,333 0.01 24 March 2004 27 October 2013
156,739 0.01 15 March 2005 11 October 2014
* Enterprise Management Incentive Scheme
Mr Hill also has a beneficial interest in 172,486 ordinary shares in the Company
representing 0.23 per cent of the Company's issued ordinary share capital of the
company.
Mr Phillips also has a beneficial interest in 744,656 ordinary shares in the
Company representing 1.00 per cent of the Company's issued ordinary share
capital of the company.
All shares and options relate to ordinary 1p shares
28 March 2006
This information is provided by RNS
The company news service from the London Stock Exchange
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.